Literature DB >> 6300255

Mechanisms of destruction of Aspergillus fumigatus hyphae mediated by human monocytes.

R D Diamond, E Huber, C C Haudenschild.   

Abstract

Normal monocytes attached to and destroyed Aspergillus hyphae by morphologic and metabolic criteria. Inhibition by anaerobiosis, azide, cyanide, halide-free conditions, catalase, histidine, and tryptophan suggested mediation of hyphal damage primarily through the myeloperoxidase system. However, myeloperoxidase-independent oxidative or nonoxidative mechanisms appeared active in hyphal damage by monocytes from patients with myeloperoxidase deficiency or chronic granulomatous disease (CGD). Moreover, hyphae were damaged by lysates and granule-enriched fractions of monocytes from patients with CGD, whereas comparable fractions of normal monocytes were active only with added halide and H2O2. Hyphal damage by both whole monocytes and granule-enriched fractions from patients with CGD was inhibited by polyanions, a result suggesting that cationic proteins may be involved. Hyphal damage by normal monocytes or monocytes from patients with CGD was inhibited by cells that lacked antihyphal activity (chlorpromazine-treated normal neutrophils or neutrophils from patients with CGD, respectively). This effect may predispose patients with CGD to chronic, invasive aspergillosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300255     DOI: 10.1093/infdis/147.3.474

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

Review 1.  Innate immunity to Aspergillus species.

Authors:  Stacy J Park; Borna Mehrad
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

2.  Proceedings of the British Thoracic Society. 6-7 December 1984, London. Abstracts.

Authors: 
Journal:  Thorax       Date:  1985-03       Impact factor: 9.139

3.  Resistance of spores of Aspergillus fumigatus to ingestion by phagocytic cells.

Authors:  M D Robertson; A Seaton; L J Milne; J A Raeburn
Journal:  Thorax       Date:  1987-06       Impact factor: 9.139

4.  Host defence to pulmonary mycosis.

Authors:  C H Mody; P W Warren
Journal:  Can J Infect Dis       Date:  1999-03

5.  Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography.

Authors:  R G Washburn; D J DeHart; D E Agwu; B J Bryant-Varela; N C Julian
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

6.  Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways.

Authors:  R G Washburn; J I Gallin; J E Bennett
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage.

Authors:  R A Salata; R D Pearson; J I Ravdin
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

Review 8.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

9.  Acquired immunity in experimental murine aspergillosis is mediated by macrophages.

Authors:  L de Repentigny; S Petitbois; M Boushira; E Michaliszyn; S Sénéchal; N Gendron; S Montplaisir
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury.

Authors:  Cristina Gil-Lamaignere; Emmanuel Roilides; Caron A Lyman; Maria Simitsopoulou; Theodouli Stergiopoulou; Avgi Maloukou; Thomas J Walsh
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.